David Graham
0000-0002-6908-8317
11 papers found
Refreshing results…
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus
Twice‐a‐day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or L a ctobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori . Two randomized pilot studies
Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment-authors' reply
High‐dose PPI‐amoxicillin dual therapy with or without bismuth for first‐line Helicobacter pylori therapy: A randomized trial
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment
Enzyme therapy for functional bowel disease-like post-prandial distress: Enzymes in functional bowel disease
Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency
Brief report: Lactobacillus bulgaricus GLB44 (Proviotic™ ) plus esomeprazole for Helicobacter pylori eradication: A pilot study
Editorial: Helicobacter pylori and gastric cancer in Alaskan Natives: Time to stop studying H. pylori and to eradicate it
Mechanical colon cleansing for screening colonoscopy: A randomized controlled trial: Comparison of colon cleansing methods
Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis
Missing publications? Search for publications with a matching author name.